01/30/2023
Stockholders Approve Proposal One Clearing Way for Consummation of Merger
RICHLAND, WASHINGTON – January 30, 2023 ...
01/12/2023
RICHLAND, WASHINGTON – January 12, 2023 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
12/14/2022
RICHLAND, WASHINGTON – December 14, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
11/10/2022
Revenue Increased 12% Year-Over-Year
Record Non-Prostate Brachytherapy Revenue Increased 28% ...
10/31/2022
Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – October 31, ...
10/18/2022
RICHLAND, WA and CORALVILLE, IA – October 18, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology ...
09/28/2022
RICHLAND, WASHINGTON – September 28, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
09/21/2022
Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – September 21, 2022 ...
06/21/2022
RICHLAND, WASHINGTON – June 21, 2022 – The growing body of information regarding Isoray, Inc.’s (NYSE American: ...
06/15/2022
RICHLAND, WASHINGTON – June 15, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and ...
05/10/2022
Revenue Increased 12% Year-Over-Year
Record Non-Prostate Brachytherapy Revenue Increased 28% ...
04/29/2022
Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – April 29, 2022 – ...
Media & Public Relations Contact
If you have questions or need help, please contact Sharon Schultz:
Sharon Schultz
Public and Media Relations